UBS Downgrades Cabot to Neutral, Lowers Price Target to $87
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Joshua Spector has downgraded Cabot (NYSE:CBT) from Buy to Neutral and reduced the price target from $90 to $87, indicating a more cautious outlook on the company's stock.
January 08, 2024 | 12:17 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
UBS analyst downgrades Cabot to Neutral and lowers price target to $87, suggesting a tempered expectation for the stock's performance.
The downgrade from Buy to Neutral by a major analyst like UBS suggests that they see limited upside potential or increased risk in Cabot's stock. This could lead to a negative investor sentiment in the short term and potentially cause a decrease in the stock price as the market adjusts to the new rating and price target.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100